KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	Dexrazoxane (DRZ) plus Mitoxantrone (MX)	[2] Dexrazoxane, Mitoxantrone	[3] D02166 (Name: Mitoxantrone hydrochloride), D03730 , D08224 (Name: Mitoxantrone)	[2] TOP2A, TOP2B 💬	[1] Platinum drug resistance 💬	[1] 13
2	Glatiramer acetate 20 mg, with mitoxantrone	[3] Acetate, Glatiramer, Mitoxantrone	[3] D02166 (Name: Mitoxantrone hydrochloride), D04318 , D08224 (Name: Mitoxantrone)	[22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬	[33] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬	[1] 13
3	Mitoxantrone	[1] Mitoxantrone	[2] D02166 (Name: Mitoxantrone hydrochloride), D08224 (Name: Mitoxantrone)	[2] TOP2A, TOP2B 💬	[1] Platinum drug resistance 💬	[1] 13
4	Other: mitoxantrone - immunomodulator	[1] Mitoxantrone	[2] D02166 (Name: Mitoxantrone hydrochloride), D08224 (Name: Mitoxantrone)	[2] TOP2A, TOP2B 💬	[1] Platinum drug resistance 💬	[1] 13